
    
      his study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow
      Derived Autologous mono nuclear cells (100 Million per dose).trial to be conducted for 36
      months in patients with diabetes Mellitus in India,Primary outcome measure are abolition or
      reduction of insulin by>50 percentage by the end of 6 months of ABMSCT-Any reduction in
      requirement of Insulin dosage and Improvement in HbA1C Level.
    
  